Literature DB >> 12598332

Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.

Denis Furling1, Le Thanh Lam, Onnik Agbulut, Gillian S Butler-Browne, Glenn E Morris.   

Abstract

Myotonic dystrophy (DM1) is caused by the expansion of a CTG repeat in the noncoding region of a protein kinase, DMPK, expressed in skeletal and cardiac muscles. The aim of the present study was to determine the effects of very large CTG expansions on DMPK expression and skeletal muscle development. In fetuses suffering from the severe congenital form of DM1 with large CTG expansions (1800 to 3700 repeats), the skeletal muscle level of DMPK was reduced to 57% of control levels and a similar reduction was observed in cultured DM1 muscle cells relative to control cultures. These results are consistent with greatly reduced DMPK expression from the mutant allele and normal expression from the unaffected allele in this autosomal dominant disorder. In normal fetuses, DMPK protein levels increased dramatically between 9 and 16 weeks and remained high throughout the remaining gestation period. DM1 fetuses showed impaired skeletal muscle development, characterized by a persistence of embryonic and fetal myosin heavy chains and almost total absence of slow myosin heavy chains at the end of gestation. DMPK expression, however, was similar in both fast and slow fibers from normal adult muscle. The reduced DMPK and the delayed slow fiber maturation in congenital DM1 may be two separate consequences of nuclear retention of DMPK RNA transcripts with expanded CUG repeats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598332      PMCID: PMC1868110          DOI: 10.1016/s0002-9440(10)63894-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

1.  The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein.

Authors:  S Manilal; T M Nguyen; C A Sewry; G E Morris
Journal:  Hum Mol Genet       Date:  1996-06       Impact factor: 6.150

2.  Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.

Authors:  H Seznec; O Agbulut; N Sergeant; C Savouret; A Ghestem; N Tabti; J C Willer; L Ourth; C Duros; E Brisson; C Fouquet; G Butler-Browne; A Delacourte; C Junien; G Gourdon
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

3.  A discrepancy resolved: human satellite cells are not preprogrammed to fast and slow lineages.

Authors:  S Bonavaud; O Agbulut; R Nizard; G D'honneur; V Mouly; G Butler-Browne
Journal:  Neuromuscul Disord       Date:  2001-11       Impact factor: 4.296

4.  Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.

Authors:  A Mankodi; C R Urbinati; Q P Yuan; R T Moxley; V Sansone; M Krym; D Henderson; M Schalling; M S Swanson; C A Thornton
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

5.  Myotonic protein kinase expression in human and bovine lenses.

Authors:  P W Dunne; L Ma; D L Casey; H F Epstein
Journal:  Biochem Biophys Res Commun       Date:  1996-08-05       Impact factor: 3.575

6.  Immaturity of muscle fibers in the congenital form of myotonic dystrophy: its consequences and its origin.

Authors:  E Farkas-Bargeton; J P Barbet; S Dancea; R Wehrle; A Checouri; O Dulac
Journal:  J Neurol Sci       Date:  1988-02       Impact factor: 3.181

7.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

8.  Maturational arrest of fetal muscle in neonatal myotonic dystrophy. A pathologic study of four cases.

Authors:  H B Sarnat; S W Silbert
Journal:  Arch Neurol       Date:  1976-07

9.  Denervation of newborn rat muscle does not block the appearance of adult fast myosin heavy chain.

Authors:  G S Butler-Browne; L B Bugaisky; S Cuénoud; K Schwartz; R G Whalen
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

10.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.

Authors:  D Bader; T Masaki; D A Fischman
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more
  10 in total

1.  Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.

Authors:  Erin B Harmon; Michelle L Harmon; Tricia D Larsen; Jie Yang; Joseph W Glasford; M Benjamin Perryman
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes.

Authors:  Diana M Dincã; Louison Lallemant; Anchel González-Barriga; Noémie Cresto; Sandra O Braz; Géraldine Sicot; Laure-Elise Pillet; Hélène Polvèche; Paul Magneron; Aline Huguet-Lachon; Hélène Benyamine; Cuauhtli N Azotla-Vilchis; Luis E Agonizantes-Juárez; Julie Tahraoui-Bories; Cécile Martinat; Oscar Hernández-Hernández; Didier Auboeuf; Nathalie Rouach; Cyril F Bourgeois; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

3.  HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.

Authors:  Debra A O'Leary; Leonardo Vargas; Orzala Sharif; Michael E Garcia; Yury J Sigal; Siu-Kei Chow; Christian Schmedt; Jeremy S Caldwell; Achim Brinker; Ingo H Engels
Journal:  Curr Chem Genomics       Date:  2010-03-19

4.  Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Authors:  Ian Holt; Virginie Jacquemin; Majid Fardaei; Caroline A Sewry; Gillian S Butler-Browne; Denis Furling; J David Brook; Glenn E Morris
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

5.  Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development.

Authors:  K Natalie Randles; Le Thanh Lam; Caroline A Sewry; Megan Puckelwartz; Denis Furling; Manfred Wehnert; Elizabeth M McNally; Glenn E Morris
Journal:  Dev Dyn       Date:  2010-03       Impact factor: 3.780

6.  A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.

Authors:  Anke E E G Gudde; Anchel González-Barriga; Walther J A A van den Broek; Bé Wieringa; Derick G Wansink
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

Review 7.  LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.

Authors:  Barbara Rizzacasa; Elena Morini; Sabina Pucci; Michela Murdocca; Giuseppe Novelli; Francesca Amati
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

Review 8.  Cells of Matter-In Vitro Models for Myotonic Dystrophy.

Authors:  Magdalena Matloka; Arnaud F Klein; Frédérique Rau; Denis Furling
Journal:  Front Neurol       Date:  2018-05-23       Impact factor: 4.003

Review 9.  Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1.

Authors:  Sylvia Nieuwenhuis; Kees Okkersen; Joanna Widomska; Paul Blom; Peter A C 't Hoen; Baziel van Engelen; Jeffrey C Glennon
Journal:  Front Neurol       Date:  2019-11-26       Impact factor: 4.003

10.  Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1.

Authors:  Peter K Todd; Feras Y Ackall; Junguk Hur; Kush Sharma; Henry L Paulson; James J Dowling
Journal:  Dis Model Mech       Date:  2013-10-02       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.